Viscoelastic guidance of resuscitation

Current Opinion in Anaesthesiology

Volumn 27, Issue 2, 2014, Pages 212-218

  Stensballe, Jakob ^a   Ostrowski, Sisse R ^a   Johansson, Pär I ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

coagulopathy; resuscitation; trauma; viscoelastic hemostatic monitoring

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; GELATIN; PROTAMINE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STARCH; TRANEXAMIC ACID;

BLOOD CLOT; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CLASSIFICATION ALGORITHM; COLLOID; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; HEMATOLOGICAL PROCEDURE; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MORTALITY; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; REVIEW; ROTATIONAL THROMBELASTOMETRY; THORAX SURGERY; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; VISCOELASTIC HEMOSTATIC ASSAY; VISCOELASTICITY; FIBRINOLYSIS; WOUNDS AND INJURIES;

BLOOD TRANSFUSION; FIBRINOLYSIS; HEMOSTASIS; HUMANS; RESUSCITATION; THROMBELASTOGRAPHY; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 84896398628     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000051     Document Type: Review

References (52)

1. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22:1381-1389.
2. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007; 13:680-685. (Pubitemid 350059533)
3. Johansson PI, Stensballe J, Ostrowski S.R. Current management of massive hemorrhage in trauma. Scand J Trauma Resusc Emerg Med 2012; 20:47.
4. Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg 2011; 254:10-19.
5. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski S.R. High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg 2012; 72:428-436.
6. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski S.R. A high admission Syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011; 254:194-200.
7. Johansson PI, Ostrowski S.R. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses 2010; 75:564-567.
8. Rivard GE, Brummel-Ziedins KE, Mann KG, et al. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005; 3:2039-2043. (Pubitemid 43086062)
9. Johansson PI, Svendsen MS, Salado J, et al. Investigation of the thrombingenerating capacity, evaluated by thrombogram, and clot formation evaluated by thrombelastography of platelets stored in the blood bank for up to 7 days. Vox Sang 2008; 94:113-118.
10. Johansson PI. Coagulation monitoring of the bleeding traumatized patient. Curr Opin Anaesthesiol 2012; 25:235-241.
11. Hoffman M, Cichon LJ. Practical coagulation for the blood banker. Transfusion 2013; 53:1594-1602.
12. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013; 110:3507-3512.
13. Young G, Sorensen B, Dargaud Y, et al. Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood 2013; 121:1944-1950.
14. Schochl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009; 67:125-131.
15. Kashuk JL, Moore EE, Sawyer M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010; 252:434-442.
16. Solomon C, Sorensen B, Hochleitner G, et al. Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry. Anesth Analg 2012; 114:721-730.
17. Theusinger OM, Madjdpour C, Spahn DR. Resuscitation and transfusion management in trauma patients: emerging concepts. Curr Opin Crit Care 2012; 18:661-670.
18. Pham HP, Shaz BH. Update on massive transfusion. Br J Anaesth 2013; 111 (Suppl. 1):i71-i82.
19. Johansson PI, Stissing T, Bochsen L, Ostrowski S.R. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009; 17:45.
20. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256:476-486.
21. Afshari A, Wikkelso A, Brok J, et al. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011; 3:CD007871.
22. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117:531-547.
23. Johansson PI. Hemostatic strategies for minimizing mortality in surgery with major blood loss. Curr Opin Hematol 2009; 16:509-514.
24. Johansson PI, Stensballe J. Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets-a review of the current literature. Transfusion 2010; 50:701-710.
25. Johansson PI. The blood bank: from provider to partner in treatment of massively bleeding patients. Transfusion 2007; 47:176S-181S. (Pubitemid 47094148)
26. Johansson PI, Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang 2009; 96:111-118.
27. Johansson PI, Sorensen AM, Larsen CF, et al. Low hemorrhage-related mortality in trauma patients in a Level I trauma center employing transfusion packages and early thromboelastography-directed hemostatic resuscitation with plasma and platelets. Transfusion 2013; 53:3088-3099.
28. Kashuk JL, Moore EE, Wohlauer M, et al. Initial experiences with point-of-care rapid thrombelastography for management of life-threatening postinjury coagulopathy. Transfusion 2012; 52:23-33.
29. Tapia NM, Chang A, Norman M, et al. TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg 2013; 74:378-386.
30. Gaarder C, Naess PA, Frischknecht CE, et al. Scandinavian Guidelines-'The massively bleeding patient'. Scand J Surg 2008; 97:15-36. (Pubitemid 351449961)
31. Hess JR, Johansson PI, Holcomb JB. Trauma and massive transfusion. In: Mintz PD, editor. Transfusion therapy: clinical principles and practice, 3rd ed. Bethesda: American Association of Blood Banks (AABB); 2010.
32. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17:R76.
33. Theusinger OM,Wanner GA, Emmert MY, et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM(R)) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011; 113:1003-1012.
34. Cotton BA, Harvin JA, Kostousouv V, et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg 2012; 73:365-370.
35. Chapman MP, Moore EE, Ramos CR, et al. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg 2013; 75:961-967.
36. Henry DA, Carless PA, Moxey AJ, et al. Antifibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; CD001886.
37. Alshryda S, Sarda P, Sukeik M, et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011; 93:1577-1585.
38. CRASH-2 Trial collaborators. Roberts I, Shakur H, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377:1096-1101; 1101.e1-1101.e2.
39. Peitsidis P, Kadir RA. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother 2011; 12:503-516.
40. Ker K, Edwards P, Perel P, et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344:e3054.
41. Hutton B, Joseph L, Fergusson D, et al. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. BMJ 2012; 345:e5798.
42. Shi J, Wang G, Lv H, et al. Tranexamic acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up. Ann Thorac Surg 2013; 95:795-802.
43. CRASH-2 Trial collaborators. Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebocontrolled trial. Lancet 2010; 376: 23-32.
44. Holcomb JB, del Junco DJ, Fox EE, et al. The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013; 148:127-136.
45. Nascimento B, Callum J, Tien H, et al. Effect of a fixed-ratio (1 : 1 : 1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ 2013; 185:E583-E589.
46. Kelly JM, Callum JL, Rizoli SB. 1 : 1 : 1-Warranted or wasteful? Even where appropriate, high ratio transfusion protocols are costly: early transition to individualized care benefits patients and transfusion services. Expert Rev Hematol 2013; 6:631-633.
47. Spahn DR, Ganter MT. Towards early individual goal-directed coagulation management in trauma patients. Br J Anaesth 2010; 105:103-105.
48. Schochl H, Forster L, Woidke R, et al. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 2010; 65:199-203.
49. Schoechl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using rotation thromboelastometry (ROTEM)-guided administration of fibrinogen and prothrombin complex concentrate. Crit Care 2010; 14:R55.
50. Schoechl H, Nienaber U, Maegele M, et al. Transfusion in trauma:thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15:R83.
51. Cotton BA, Faz G, Hatch QM, et al. Rapid thrombelastography delivers realtime results that predict transfusion within 1 h of admission. J Trauma 2011; 71:407-417.
52. Jeger V, Zimmermann H, Exadaktylos AK. Can RapidTEG accelerate the search for coagulopathies in the patient with multiple injuries? J Trauma 2009; 66:1253-1257.